COLL
Collegium Pharmaceutical Inc
NASDAQ: COLL · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$23.23
+1.00% today
Updated 2026-10-28
Market cap
$754.97M
P/E ratio
18.26
P/S ratio
0.93x
EPS (TTM)
$1.27
Dividend yield
—
52W range
$21 – $51
Volume
0.8M
Collegium Pharmaceutical Inc (COLL) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$23.23
12-Month target
$41.56
2030 Target
—
Intrinsic (DCF)
$365.75
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.3B | $0.5B | $0.6B | $0.6B | $0.8B | $0.9B | $1.1B | $1.3B | $1.6B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 20.00% (capped 20%) · P/E: 18.26x (capped 25x) · Margin: 5.93%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.